Literature DB >> 6432799

Characterization of a transformation-sensitive protein in the extracellular matrix of chicken embryo fibroblasts.

J Blenis, S P Hawkes.   

Abstract

The extracellular matrix of cultured chicken embryo fibroblasts undergoes a number of modifications during the early stages of oncogenic transformation. One alteration is increased production of a small protein (Mr approximately 21,000) which is transiently deposited in the matrix by transforming cells infected with LA24, a temperature-sensitive mutant of Rous sarcoma virus (RSV) (Blenis, J., and Hawkes, S.P. (1983) Proc. Natl. Acad. Sci. U.S.A. 80, 770-774). This protein is a major component of substratum-associated material (material which remains attached to culture dishes after removal of cells with ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid). Its synthesis is stimulated by transformation of cells with NY68, another ts mutant of RSV, and also by treatment of normal, uninfected cells with the tumor promoter, phorbol myristate acetate. Accessibility of the 21-kDa protein to lactoperoxidase-catalyzed iodination indicates an exposed location within the matrix. The protein binds strongly to the culture dish and/or other matrix components. This interaction can be disrupted by sodium dodecyl sulfate but not by several nonionic detergents, unless beta-mercaptoethanol or KCl (0.5 M) are also present. High concentrations of urea or guanidine hydrochloride also remove the protein from the matrix. The 21-kDa protein is resistant to trypsin, collagenase, and the hydrolytic enzymes associated with cells transformed by the wild-type Prague A RSV but not to Pronase or chymotrypsin. A 21-kDa protein with properties similar to those described above is also detected in the medium and binds to the matrix, suggesting that a potential route of deposition of the 21-kDa protein in the matrix may be via shedding and subsequent interaction with other matrix components.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6432799

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  That impish TIMP: the tissue inhibitor of metalloproteinases-3.

Authors:  J F Woessner
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

Review 2.  MMPs and TIMPs--an historical perspective.

Authors:  J Frederick Woessner
Journal:  Mol Biotechnol       Date:  2002-09       Impact factor: 2.695

3.  Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts.

Authors:  T T Yang; S P Hawkes
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

4.  Regulation and function of tissue inhibitor of metalloproteinase (TIMP) 1 and TIMP3 in periovulatory rat granulosa cells.

Authors:  Feixue Li; Thomas E Curry
Journal:  Endocrinology       Date:  2009-04-23       Impact factor: 4.736

5.  Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme.

Authors:  Meng-Huee Lee; Philippa Dodds; Vandana Verma; Klaus Maskos; Vera Knäuper; Gillian Murphy
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

6.  TIMP3 Modulates GHR Abundance and GH Sensitivity.

Authors:  Yue Zhang; Xiangdong Wang; Kimberly Loesch; Larry A May; George E Davis; Jing Jiang; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2016-04-13

7.  Developmentally regulated synthesis of a low molecular weight protein (Ch 21) by differentiating chondrocytes.

Authors:  F Descalzi Cancedda; P Manduca; C Tacchetti; P Fossa; R Quarto; R Cancedda
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

Review 8.  Classical and novel GH receptor signaling pathways.

Authors:  Stuart J Frank
Journal:  Mol Cell Endocrinol       Date:  2020-08-22       Impact factor: 4.102

9.  Biochemical and immunohistochemical analysis of tissue inhibitor of metalloproteinases-1 in human sound dentin.

Authors:  Pietro Gobbi; Tatjana Maravic; Allegra Comba; Claudia Mazzitelli; Edoardo Mancuso; Mirella Falconi; Lorenzo Breschi; Annalisa Mazzoni
Journal:  Clin Oral Investig       Date:  2021-02-10       Impact factor: 3.573

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.